Bristol Myers Squibb, Amgen and Pfizer approach steepest patent cliffs among large drugmakers December 29, 2021 Los Angeles Biotechnology Network News Los Angeles Biotech News Comments Off on Bristol Myers Squibb, Amgen and Pfizer approach steepest patent cliffs among large drugmakers Bristol Myers Squibb, Amgen and Pfizer approach steepest patent cliffs among large drugmakers aliu Wed, 12/29/2021 – 10:04